Inbiomotion SL

@inbiomotion

Addressing a clear unmet medical need in the personalized adjuvant treatment of early-stage breast cancer.

Barcelona Katılım Ocak 2021

38 Takip Edilen49 Takipçiler

Inbiomotion SL@inbiomotion·30 Eyl

Inbiomotion’s MAF Test® selects breast cancer patients benefitting from adjuvant clodronate, significantly improving their overall survival. inbiomotion.com/news/

English

Keşfet

@elonmusk @BarackObama @taylorswift13 @cristiano @BillGates @NASA @nikifrancismediavine @katyperry